AMITABH SINGH: Open Payments
NPI 1053843540 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,018 in 146 payments from 31 companies in 2025. Trend: 2023 $3,707 · 2024 $4,450 · 2025 $4,018
Food & beverage: $3,986Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $506 |
| Dexcom, Inc. | 11 | $338 |
| Braeburn Inc. | 22 | $306 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $250 |
| AstraZeneca Pharmaceuticals LP | 3 | $249 |
| Daiichi Sankyo Inc. | 7 | $247 |
| Axsome Therapeutics, Inc. | 6 | $215 |
| ABBVIE INC. | 17 | $211 |
| Boston Scientific Corporation | 1 | $183 |
| Amgen Inc. | 6 | $178 |
Products named: Ozempic, BRIXADI, Kerendia, INJECTAFER, Dexcom G6 Transmitter, TEZSPIRE, Auvelity, Axios.
Industry payments across CA — which companies pay providers there.
